Barbara Kahn is Director of DEXCOM INC. Currently has a direct ownership of 0 shares of DXCM, which is worth approximately $0. The most recent transaction as insider was on May 18, 2024, when has been sold 2,927 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
100.0% 12M change
Total Value Held $0

BARBARA KAHN Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 18 2024
SELL
Bona fide gift
-
2,927 Reduced 100.0%
0 Common Stock
May 18 2023
SELL
Bona fide gift
-
3,976 Reduced 57.6%
2,927 Common Stock
May 18 2023
BUY
Grant, award, or other acquisition
-
2,927 Added 29.78%
6,903 Common Stock
May 20 2022
BUY
Grant, award, or other acquisition
-
994 Added 50.0%
994 Common Stock
May 19 2022
SELL
Other acquisition or disposition
-
918 Reduced 100.0%
0 Common Stock
May 21 2021
BUY
Grant, award, or other acquisition
-
918 Added 50.0%
918 Common Stock
May 20 2021
SELL
Other acquisition or disposition
-
787 Reduced 100.0%
0 Common Stock
BK

Barbara Kahn

Director
San Diego, CA

Track Institutional and Insider Activities on DXCM

Follow DEXCOM INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DXCM shares.

Notify only if

Insider Trading

Get notified when an Dexcom Inc insider buys or sells DXCM shares.

Notify only if

News

Receive news related to DEXCOM INC

Track Activities on DXCM